RevivBio Inc. — Form D/A
RevivBio Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2022-10-04. The offering totals $500K, of which $400K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-10-04
- Form: D/A
- Accession: 0001878646-22-000045
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $400K
- Remaining: $100K
- Investors: 6
- Date of first sale: 2022-06-10
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-451168
Issuer
- Name: RevivBio Inc.
- CIK: 0001935963
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 750 MAIN STREET, CAMBRIDGE, MA, 02139
- Phone: 607-227-2947
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| OXANA AILEEN KUKHANEVA | Director | PARIS, I0 |
| KARLA AILEEN MILCIC | Director | CAMBRIDGE, MA |
| FATEMEH AILEEN MASTOURI | Director | CAMBRIDGE, MA |
| FATEMEH AILEEN MASTOURI | Executive Officer | CAMBRIDGE, MA |
Other filings by this issuer (2)
More